Guggenheim Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $766K | Sell |
|
|||||
|
2025
Q2 | $666K | Buy |
|
|||||
|
2025
Q1 | $773K | Buy |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $1.09M | Buy |
|
|||||
|
2024
Q2 | $1.29M | Buy |
|
|||||
|
2024
Q1 | $1.97M | Buy |
|
|||||
|
2023
Q4 | $1.89M | Sell |
|
|||||
|
2023
Q3 | $1.56M | Buy |
|
|||||
|
2023
Q2 | $2.87M | Sell |
|
|||||
|
2023
Q1 | $2.37M | Sell |
|
|||||
|
2022
Q4 | $2.52M | Buy |
|
|||||
|
2022
Q3 | $2.43M | Sell |
|
|||||
|
2022
Q2 | $1.88M | Sell |
|
|||||
|
2022
Q1 | $2.19M | Sell |
|
|||||
|
2021
Q4 | $2.28M | Buy |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|